A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer

By Gershanovich M.  

Breast Cancer Research and Treatment, Vol. 45, Iss. 3, 1997-09 ,pp. : 251-262

Springer Publishing Company

Access to resources Recommend Favorite

Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer

By Buzdar A.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 2, 2002-05 ,pp. : 161-175

Springer Publishing Company

Access to resources Recommend Favorite

Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis

By Peethambaram P.P.   Ingle J.N.   Suman V.J.   Hartmann L.C..   Loprinzi C.L.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 2, 1999-03 ,pp. : 117-122

Springer Publishing Company

Access to resources Recommend Favorite

Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials

By Zhou Wen-Bin  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 625-631

Springer Publishing Company

Access to resources Recommend Favorite

A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

By Johnston S.   Gumbrell L.   Evans T.   Coleman R.   Smith I.   Twelves C.   Soukop M.   Rea D.   Earl H.   Howell A.   Jones A.   Canney P.   Powles T.   Haynes B.   Nutley B.   Grimshaw R.   Jarman M.   Halbert G.   Brampton M.   Haviland J.   Dowsett M.   Coombes R.  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 341-348

Springer Publishing Company

Access to resources Recommend Favorite